Cannabidiol usage, efficacy, and side effects: analyzing the impact of health conditions, medications, and cannabis use in a cross-sectional online pilot study

StatusVoR
Simple item page
cris.lastimport.scopus2024-09-03T03:10:56Z
dc.abstract.enBackground: Products containing cannabidiol (CBD) are attracting attention because of their potential therapeutic benefits and positive impacts on well-being and mental health. Although additional research is needed to understand their effectiveness in treating mental disorders, cross-sectional studies may help identify the factors influencing CBD use patterns. This study examined the impact of variables such as health status, medication use, medical supervision, gender, age, and cannabis use on CBD consumption patterns. Materials and methods: A self-selected sample (n =267) of current or former CBD users was recruited via social media and participated in an online survey designed to collect data on basic demographics, health status, cannabis use, and CBD usage patterns. Results: The sample (n = 267) consisted of 68.5% women with an average age of 30.21 years, of which 25.8% reported diagnosed psychiatric disorders and 49.4% reported cannabis use. The top five reasons for using CBD were self-reported stress (65.3%), sleep problems (51.7%), overall improvement in well-being (52.5%), improved mood (44.9%), and anxiety relief (40.9%). Our findings suggest that individuals with psychiatric disorders and those taking psychotropic medications are more likely to use CBD to relieve stress and anxiety. Overall, nearly 70% of the individuals found CBD products to be effective. Sublingual administration was more popular among non-cannabis users, while cannabis users preferred smoking and vaping to CBD administration. Conclusion: Our results indicate that individuals using CBD for health and wellness reasons believe that it has potential health benefits. Further research using rigorous longitudinal designs is needed to delve deeper into the effectiveness of low-dose CBD and to better understand the therapeutic potential of CBD.
dc.affiliationCentrum Badań Neuropoznawczych
dc.affiliationWydział Psychologii w Warszawie
dc.affiliationInstytut Psychologii
dc.contributor.authorBinkowska, Alicja
dc.contributor.authorJakubowska, Natalia
dc.contributor.authorRedeł, Anna
dc.contributor.authorLaskowska, Sandra
dc.contributor.authorSzlufik, Stanisław
dc.contributor.authorBrzezicka, Aneta
dc.date.access2024-02-29
dc.date.accessioned2024-05-15T09:31:59Z
dc.date.available2024-05-15T09:31:59Z
dc.date.created2024-02-07
dc.date.issued2024-02-29
dc.description.abstract<jats:sec><jats:title>Background</jats:title><jats:p>Products containing cannabidiol (CBD) are attracting attention because of their potential therapeutic benefits and positive impacts on well-being and mental health. Although additional research is needed to understand their effectiveness in treating mental disorders, cross-sectional studies may help identify the factors influencing CBD use patterns. This study examined the impact of variables such as health status, medication use, medical supervision, gender, age, and cannabis use on CBD consumption patterns.</jats:p></jats:sec><jats:sec><jats:title>Materials and methods</jats:title><jats:p>A self-selected sample (n =267) of current or former CBD users was recruited via social media and participated in an online survey designed to collect data on basic demographics, health status, cannabis use, and CBD usage patterns.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The sample (n = 267) consisted of 68.5% women with an average age of 30.21 years, of which 25.8% reported diagnosed psychiatric disorders and 49.4% reported cannabis use. The top five reasons for using CBD were self-reported stress (65.3%), sleep problems (51.7%), overall improvement in well-being (52.5%), improved mood (44.9%), and anxiety relief (40.9%). Our findings suggest that individuals with psychiatric disorders and those taking psychotropic medications are more likely to use CBD to relieve stress and anxiety. Overall, nearly 70% of the individuals found CBD products to be effective. Sublingual administration was more popular among non-cannabis users, while cannabis users preferred smoking and vaping to CBD administration.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Our results indicate that individuals using CBD for health and wellness reasons believe that it has potential health benefits. Further research using rigorous longitudinal designs is needed to delve deeper into the effectiveness of low-dose CBD and to better understand the therapeutic potential of CBD.</jats:p></jats:sec>
dc.description.accesstimeat_publication
dc.description.physical1-13
dc.description.versionfinal_published
dc.description.volume15
dc.identifier.doi10.3389/fpsyt.2024.1356009
dc.identifier.issn1664-0640
dc.identifier.urihttps://share.swps.edu.pl/handle/swps/672
dc.identifier.weblinkhttps://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1356009/full
dc.languageen
dc.pbn.affiliationpsychologia
dc.rightsCC-BY
dc.rights.questionYes_rights
dc.rights.urihttps://creativecommons.org/licenses/by/3.0
dc.share.articleOPEN_JOURNAL
dc.subject.encannabis
dc.subject.encannabidiol
dc.subject.enCBD
dc.subject.enanxiety
dc.subject.endepression
dc.subject.ensleep
dc.subject.enhealth
dc.subject.enstress
dc.swps.sciencecloudsend
dc.titleCannabidiol usage, efficacy, and side effects: analyzing the impact of health conditions, medications, and cannabis use in a cross-sectional online pilot study
dc.title.journalFrontiers in Psychiatry
dc.typeJournalArticle
dspace.entity.typeArticle